UOC
SBRA icon

UBS O'Connor’s Sabra Healthcare REIT SBRA Stock Holding History

UBS O'Connor’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-352,238
Closed -$6.56M – 559
2024
Q3 		$6.56M Sell
352,238
-5,492
-2% -$92.6K 0.16% 71
2024
Q2 		$5.51M Buy
357,730
+172,080
+93% +$2.46M 0.16% 95
2024
Q1 		$2.74M Sell
185,650
-50,773
-21% -$703K 0.08% 136
2023
Q4 		$3.37M Sell
236,423
-375,961
-61% -$5.34M 0.11% 107
2023
Q3 		$8.54M Buy
612,384
+95,142
+18% +$1.22M 0.15% 66
2023
Q2 		$6.09M Buy
517,242
+278,518
+117% +$3.17M 0.13% 93
2023
Q1 		$2.75M Buy
+238,724
New +$2.95M 0.07% 221
2022
Q4 		– Sell
-251,789
Closed -$3.3M – 271
2022
Q3 		$3.3M Buy
251,789
+7,544
+3% +$111K 0.04% 420
2022
Q2 		$3.41M Buy
+244,245
New +$3.27M 0.04% 438
2022
Q1 		– Sell
-64,700
Closed -$876K – 196
2021
Q4 		$876K Sell
64,700
-174,400
-73% -$2.47M 0.01% 663
2021
Q3 		$3.52M Buy
239,100
+188,800
+375% +$3.19M 0.03% 394
2021
Q2 		$915K Sell
50,300
-50,900
-50% -$906K 0.01% 572
2021
Q1 		$1.76M Buy
+101,200
New +$1.78M 0.03% 486
2020
Q4 		– Sell
-431,700
Closed -$5.95M – 636
2020
Q3 		$5.95M Buy
431,700
+256,580
+147% +$3.77M 0.15% 96
2020
Q2 		$2.53M Buy
+175,120
New +$2.3M 0.06% 209
2020
Q1 		– Sell
-136,800
Closed -$2.92M – 389
2019
Q4 		$2.92M Buy
+136,800
New +$3.06M 0.08% 175
2018
Q4 		– Sell
-165,300
Closed -$3.82M – 284
2018
Q3 		$3.82M Buy
165,300
+78,000
+89% +$1.77M 0.09% 127
2018
Q2 		$1.9M Buy
87,300
+51,587
+144% +$1.01M 0.04% 166
2018
Q1 		$630K Sell
35,713
-64,287
-64% -$1.13M 0.01% 256
2017
Q4 		$1.88M Sell
100,000
-217,000
-68% -$4.32M 0.03% 213
2017
Q3 		$6.96M Buy
+317,000
New +$7.16M 0.1% 162

Other funds holding SBRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS O'Connor's SBRA Position: Q4 2024 in Review

UBS O'Connor sold out of Sabra Healthcare REIT (SBRA) in Q4 2024, closing a stake of 352,238 shares — an estimated $6.56M sold.

UBS O'Connor first reported a position in SBRA in Q3 2017 and held it in 21 quarters. The position peaked at $8.54M in Q3 2023. 389 funds tracked by Wall St. Rank hold SBRA as of Q4 2024.

  • UBS O'Connor reported no remaining Sabra Healthcare REIT position as of Q4 2024 after selling out during the quarter.
  • UBS O'Connor sold 352,238 Sabra Healthcare REIT shares in Q4 2024, an estimated $6.56M.
  • UBS O'Connor first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 21 quarters.
  • UBS O'Connor's Sabra Healthcare REIT position peaked at $8.54M in Q3 2023.
  • 389 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.